• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    14.44 Up 1.00(7.44%) Mar 31, 4:00PM EDT
    |After Hours : 14.54 Up 0.10 (0.69%) Mar 31, 6:27PM EDT
    Add to Portfolio
    Prev Close:13.44
    Open:13.45
    Bid:13.90 x 1000
    Ask:14.53 x 2700
    1y Target Est:13.67
    Beta:0.94
    Next Earnings Date:N/A
    Day's Range:13.25 - 14.99
    52wk Range:2.46 - 14.99
    Volume:1,872,426
    Avg Vol (3m):1,489,710
    Market Cap:392.88M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSUp 7.44%392.88M
    BVTI 0.00%N/A
    DNDN 0.00%N/A
    VICLUp 4.99%85.40M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):365.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.10
    Quarterly EPS Est (Apr-15) :-0.28
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback